Clinical Trial Update: Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and Fatigue [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is examining whether iron supplementation affects cerebral dopamine receptor density in non-anaemic premenopausal women with low ferrit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Iron Deficiency

Drugs mentioned

• Iron supplement

Snippet

Sponsor: Albina Nowak, MD | Conditions: Fatigue, Iron-deficiency | Phase 4 | Status: UNKNOWN